Castle Biosciences SG&A Expense (Quarterly) Trends

Castle Biosciences Inc (CSTL)

24.33 +1.49 (+6.52%) USD | NASDAQ | May 03, 16:00

24.28 -0.05 (-0.21%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2018. Upgrade now.

Date	Value
March 31, 2024	48.50M
December 31, 2023	44.09M
September 30, 2023	44.62M
June 30, 2023	44.68M
March 31, 2023	46.76M
December 31, 2022	38.43M
September 30, 2022	36.63M
June 30, 2022	37.50M
March 31, 2022	30.45M
December 31, 2021	25.16M
September 30, 2021	22.60M
June 30, 2021	20.82M
March 31, 2021	18.16M

Date	Value
December 31, 2020	14.96M
September 30, 2020	11.70M
June 30, 2020	10.39M
March 31, 2020	11.08M
December 31, 2019	9.852M
September 30, 2019	7.122M
June 30, 2019	6.821M
March 31, 2019	6.047M
December 31, 2018	4.165M
September 30, 2018	3.918M
June 30, 2018	4.160M
March 31, 2018	4.228M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

6.821M

Minimum

Jun 2019

48.50M

Maximum

Mar 2024

26.52M

Average

23.88M

Median

SG&A Expense (Quarterly) Benchmarks